脑部放疗，上午比下午敏感许多！
( V, e" r- D+ k3 p$ K( g) r: b, C
$ f: n# @$ R" G3 L; F4 d
3 y2 E4 I7 q+ dCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.) E% x& r# o8 Z4 b
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?- }0 @' W# g' H) H3 T' o
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T./ ~# A3 M$ T+ ~: W! I
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
$ O7 b# A3 P, ~! G% ~0 G% t# L- C/ R q+ o; T: L: q3 M
Abstract
6 D) l3 t# p# ^% KBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.8 p5 |; ?3 i9 ?* q$ `. D( D) f) K
0 l1 B) _6 z7 C3 H* E6 \; A
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
b0 M2 i+ K0 ?# o0 `" b
. x2 D/ t& `% U) E4 [ N% v7 }RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
' G6 y# p. [7 p6 @7 x' q7 ]2 `2 b. I% `5 p, S1 c! \
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.+ y/ k: B9 T/ U0 g# j
$ ]0 t# _$ Z$ I# C/ P- D, x; C: z
|
/ U( m! D: Y5 _, b
显身卡
